What Is Pharma Futures?
Pharma Futures is a multi-year, investor-led dialogue between the pharmaceutical industry and its investors about how to manage a rapidly-changing operating environment to deliver long-term value both to society and to shareholders. The project was initiated in 2004 as a scenario-planning exercise and has evolved to a more practically oriented, solutions-focused exploration of the link between sustainable pharmaceutical business models and global health outcomes.
The overarching objective of the initiative is to build trust and foster an environment in which collaborations and partnerships between industry and key stakeholders can flourish, leading to increased commercial opportunities and improved health outcomes.
- Pharma Futures 1, a scenario-planning exercise, resulted in the report, Pharma Futures: A Long-Term Value Outlook, which outlines possible future scenarios for the industry.
- Pharma Futures 2 analyzed the key value drivers for the industry and society and published Pharma Futures 2: Prescription for Long-Term Value.
- Pharma Futures 3 focused on identifying innovative, yet practical solutions – such as financing, partnerships and new business models – that will result in both commercial success and improved health outcomes in emerging markets, including India, China and Brazil. This work is reflected in the report Pharma Futures 3: Emerging Opportunities.
Each of the Pharma Futures dialogues takes place in a Working Group comprised of asset owners, sell and buy-side analysts of the industry, senior pharmaceutical executives and global health experts. The Working Group’s deliberations are enriched by interviews with a diverse set of external experts. SustainAbility provides overall project direction and facilitation as well as research support.
Click here to learn more about the current Pharma Futures 3 Working Group and other participants.
Funding of Pharma Futures
Each iteration of Pharma Futures has had a different funding model.
Pharma Futures 1 was originally made possible by allocations of seed funding in 2003 from Just Pensions, a programme of the UK Social Investment Forum and grants from UK Govt's Department of International Development, The Nathan Cummings and Rockefeller Foundations. It also received in-kind and financial contributions from participating pension funds and pharmaceutical companies.
Pharma Futures 2 was funded entirely by financial and in-kind contributions from pension funds and pharmaceutical companies.
Pharma Futures 3 was funded by pension funds and pharmaceutical companies, and a grant from the UK Government's Department for International Development to facilitate research and active participation of social entrepreneurs.
